• MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.

Deborah Watkins Bruner on Side Effects From Platinum-Based Drugs in Ovarian Cancer

June 17, 2015
Deborah Watkins Bruner, PhD, RN, FAAN

Sap Partners | Schools of Nursing | <b>Nell Hodgson Woodruff School of Nursing at Emory University</b>

Deborah Watkins Bruner, PhD, RN, FAAN, from the Nell Hodgson Woodruff School of Nursing at Emory University, discusses side effects associated with platinum-based drugs for the treatment of ovarian cancer.

Deborah Watkins Bruner, PhD, RN, FAAN, professor, Nell Hodgson Woodruff School of Nursing, Emory University, discusses side effects associated with platinum-based drugs for the treatment of ovarian cancer.

Related Content:

VideosGynecologic CancersAdverse Event Management
Better Treatment Needed for Androgen Receptor Adverse Events
Patient Perceptions, Other Factors Linked to Fear of Recurrence
High TMB, Adverse Events May Predict Immunotherapy Response in mUC